EXHIBIT 32.1

      CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT
                TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002



         In  connection  with the Annual Report of Elite  Pharmaceuticals,  Inc.
(the  "Company")  on Form 10-K for the year ended  March 31, 2006 filed with the
Securities and Exchange  Commission  (the "Report"),  I, Bernard J. Berk,  Chief
Executive Officer of the Company,  certify, pursuant to 18 U.S. C. Section 1350,
as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

         (1)      The Report fully  complies  with the  requirements  of Section
                  13(a) of the Securities Exchange Act of 1934; and

         (2)      The information  contained in the Report fairly  presents,  in
                  all material respects, the consolidated financial condition of
                  the  Company as of the dates  presented  and the  consolidated
                  result of operations of the Company for the periods presented.

Date:    June 29, 2006               /s/ Bernard J. Berk
                                     ----------------------------------
                                    Bernard J. Berk
                                    Chief Executive Officer of
                                    Elite Pharmaceuticals, Inc.

This  certification  has been  furnished  solely  pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002.

A signed  original of this  written  statement  required by Section 906 has been
provided  to  Elite  Pharmaceuticals,   Inc.  and  will  be  retained  by  Elite
Pharmaceuticals  Inc. and furnished to the Securities and Exchange Commission or
its staff upon request.